title: Ethical implications of withdrawal of experimental drugs at the conclusion of phase III trials.
authors.forename: M S
authors.initials: MS
authors.lastname: Roginsky
authors.forename: A
authors.initials: A
authors.lastname: Handley
mesh_terms: D004341:Drug Evaluation / Q000592:standards*; D004992:Ethics, Medical; D006805:Human Experimentation; D006801:Humans; D007258:Informed Consent / Q000331:legislation & jurisprudence; D007878:Legislation as Topic; D013375:Substance Withdrawal Syndrome; D014481:United States; D014486:United States Food and Drug Administration